Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population

计划入组 60 人 · 首次发布于 2023 年 2 月 13 日

A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam

计划入组 78 人 · 首次发布于 2007 年 2 月 19 日

Topical Clobetasol Propionate for Inflammatory Hand Osteoarthritis

计划入组 187 人 · 首次发布于 2026 年 9 月 10 日

Clobetasol propionate(Clobex, Clodan, Dermovate, Impeklo, Impoyz, Olux, Temovate, Tovet)

C₂₅H₃₂ClFO₅

clobetasol propionate;tazarotene

Clobetasol Propionate/Ketoconazole

Implandata Ophthalmic Products GmbH

Germany

Ziemer Ophthalmic Systems AG

Switzerland

Ophthalmic Consultants of Boston

United States

Eyenovia Launches Clobetasol Propionate Ophthalmic Suspension for Post-Ocular Surgery Inflammation and Pain

Eyenovia and Formosa Pharma Launch FDA-Approved APP13007 for Postoperative Ocular Inflammation

Health Canada Approves Apotex's CLOBIVIS for Post-Cataract Surgery Inflammation Treatment